Trying to separate three different claims about melanotan II: that it is the right molecule, that it is the right dose, and that it does something useful.
If you need three other compounds to notice the first one, you have not tested the first one.
Mechanism is not outcome, and a plausible pathway is the most expensive kind of evidence there is.
Forum consensus and published consensus diverged here about five years ago and never reconverged.
Where does the human data stop and the extrapolation start?
Is a baseline blood test really necessary before starting something like this?
My rule, after years of this: if it cannot survive being written down with the numbers attached, it is marketing.
Most of what is called evidence here is one person, one vial, one month. Same for me with melanotan II, unfortunately.
Same here.
Test one thing at a time. It feels slower and it is the only way to learn anything.